Cite
[Metastatic medullary thyroid carcinoma in a child with multiple endocrine neoplasia 2B. Efficiency of medium-term treatment with vandetanib without thyroid surgery]
MLA
D, Segura, et al. “[Metastatic Medullary Thyroid Carcinoma in a Child with Multiple Endocrine Neoplasia 2B. Efficiency of Medium-Term Treatment with Vandetanib without Thyroid Surgery].” Archives de Pediatrie : Organe Officiel de La Societe Francaise de Pediatrie, vol. 23, no. 8, Dec. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........26897b7aa14555a0fc8d6cf5d39cd531&authtype=sso&custid=ns315887.
APA
D, S., C, D., O, C., C, P., C, D., & D, P. (2015). [Metastatic medullary thyroid carcinoma in a child with multiple endocrine neoplasia 2B. Efficiency of medium-term treatment with vandetanib without thyroid surgery]. Archives de Pediatrie : Organe Officiel de La Societe Francaise de Pediatrie, 23(8).
Chicago
D, Segura, Dupuis C, Chabre O, Piolat C, Durand C, and Plantaz D. 2015. “[Metastatic Medullary Thyroid Carcinoma in a Child with Multiple Endocrine Neoplasia 2B. Efficiency of Medium-Term Treatment with Vandetanib without Thyroid Surgery].” Archives de Pediatrie : Organe Officiel de La Societe Francaise de Pediatrie 23 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........26897b7aa14555a0fc8d6cf5d39cd531&authtype=sso&custid=ns315887.